Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

CLINICAL QUESTION: In the monitoring of patients with type 1 and type 2 diabetes, what advantages does point-of-care HbA(1c) testing provide over current practice?

Original publication

DOI

10.3399/bjgp11X556290

Type

Journal

Br J Gen Pract

Publication Date

02/2011

Volume

61

Pages

139 - 140

Keywords

Adult, Child, Diabetes Mellitus, Type 1, Diabetes Mellitus, Type 2, Hemoglobin A, Glycosylated, Humans, Point-of-Care Systems, Randomized Controlled Trials as Topic, Young Adult